What is the pathophysiology of age-related macular degeneration (AMD)?

1. Lambert NG, ElShelmani H, Singh MK, Mansergh FC, Wride MA, Padilla M, et al. Risk factors and biomarkers of age-related macular degeneration. Prog Retin Eye Res. 2016 Sep. 54:64-102. [Medline]. [Full Text].

2. [Guideline] American Academy of Ophthalmology Retina/Vitreous Panel. Preferred Practice Pattern® guidelines Age-Related Macular Degeneration. AAO.org. Available at https://www.aao.org/preferred-practice-pattern/age-related-macular-degeneration-ppp-2015#references. 2015; Accessed: November 14, 2108.

3. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration. JAMA. 2004 Feb 11. 291(6):704-10. [Medline].

4. Seddon JM, Reynolds R, Maller J, Fagerness JA, Daly MJ, Rosner B. Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables. Invest Ophthalmol Vis Sci. 2009 May. 50(5):2044-53. [Medline].

5. Seddon JM, Chen CA. The epidemiology of age-related macular degeneration. Int Ophthalmol Clin. 2004 Fall. 44 (4):17-39. [Medline].

6. Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol. 1997 Feb. 123 (2):199-206. [Medline].

7. Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science. 2005 Apr 15. 308 (5720):421-4. [Medline].

8. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005 Apr 15. 308(5720):385-9. [Medline]. [Full Text].

9. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005 Apr 15. 308(5720):419-21. [Medline].

10. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci U S A. 2005 May 17. 102(20):7227-32. [Medline]. [Full Text].

11. Maller J, George S, Purcell S, Fagerness J, Altshuler D, Daly MJ, et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration. Nat Genet. 2006 Sep. 38(9):1055-9. [Medline].

12. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, Gehrs K, et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration. Nat Genet. 2006 Apr. 38(4):458-62. [Medline]. [Full Text].

13. Maller JB, Fagerness JA, Reynolds RC, Neale BM, Daly MJ, Seddon JM. Variation in complement factor 3 is associated with risk of age-related macular degeneration. Nat Genet. 2007 Oct. 39(10):1200-1. [Medline].

14. Yates JR, Sepp T, Matharu BK, Khan JC, Thurlby DA, Shahid H, et al. Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med. 2007 Aug 9. 357(6):553-61. [Medline].

15. Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, Seddon JM. Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet. 2009 Jan. 17(1):100-4. [Medline].

16. Seddon JM, Yu Y, Miller EC, Reynolds R, Tan PL, Gowrisankar S, et al. Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat Genet. 2013 Nov. 45(11):1366-70. [Medline].

17. Helgason H, Sulem P, Duvvari MR, Luo H, Thorleifsson G, Stefansson H, et al. A rare nonsynonymous sequence variant in C3 is associated with high risk of age-related macular degeneration. Nat Genet. 2013 Nov. 45(11):1371-4. [Medline].

18. Zhan X, Larson DE, Wang C, Koboldt DC, Sergeev YV, Fulton RS, et al. Identification of a rare coding variant in complement 3 associated with age-related macular degeneration. Nat Genet. 2013 Nov. 45(11):1375-9. [Medline]. [Full Text].

19. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science. 2006 Nov 10. 314(5801):992-3. [Medline].

20. Sobrin L, Reynolds R, Yu Y, Fagerness J, Leveziel N, Bernstein PS, et al. ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration. Am J Ophthalmol. 2010 Nov 29. [Medline].

21. Fritsche LG, Igl W, Bailey JN, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016 Feb. 48 (2):134-43. [Medline]. [Full Text].

22. Geerlings MJ, Kremlitzka M, Bakker B, Nilsson SC, Saksens NT, Lechanteur YT, et al. The Functional Effect of Rare Variants in Complement Genes on C3b Degradation in Patients With Age-Related Macular Degeneration. JAMA Ophthalmol. 2017 Jan 1. 135 (1):39-46. [Medline]. [Full Text].

23. Neale BM, Fagerness J, Reynolds R, Sobrin L, Parker M, Raychaudhuri S, et al. Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC). Proc Natl Acad Sci U S A. 2010 Apr 20. 107(16):7395-400. [Medline]. [Full Text].

24. Chen W, Stambolian D, Edwards AO, Branham KE, Othman M, Jakobsdottir J, et al. Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A. 2010 Apr 20. 107(16):7401-6. [Medline]. [Full Text].

25. Reynolds R, Rosner B, Seddon JM. Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. Ophthalmology. 2010 Oct. 117(10):1989-95. [Medline].

26. Kanoff J, Miller J. Pharmacogenetics of the treatment response of age-related macular degeneration with ranibizumab and bevacizumab. Semin Ophthalmol. 2013 Sep-Nov. 28(5-6):355-60. [Medline].

27. American Academy of Ophthalmology. American Academy of Ophthalmology (AAO) Retina/Vitreal Age-related macular degeneration. AAO. Available at http://guideline.gov/content.aspx?id=14275. 2008; Accessed: : December 3, 2013.

28. Donoso LA, Kim D, Frost A, Callahan A, Hageman G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2006 Mar-Apr. 51(2):137-52. [Medline].

29. Soames CJ, Sim RB. Interactions between human complement components factor H, factor I and C3b. Biochem J. 1997 Sep 1. 326 ( Pt 2):553-61. [Medline]. [Full Text].

30. Gehrs KM, Jackson JR, Brown EN, Allikmets R, Hageman GS. Complement, age-related macular degeneration and a vision of the future. Arch Ophthalmol. 2010 Mar. 128(3):349-58. [Medline].

31. US Food and Drug Administration. FDA alerts health care professionals of infection risk from repackaged Avastin intravitreal injections. Available at http://www.fda.gov/Drugs/DrugSafety/ucm270296.htm. Accessed: August 31, 2011.

32. Warwick A, Lotery A. Genetics and genetic testing for age-related macular degeneration. Eye (Lond). 2018 May. 32 (5):849-857. [Medline].

33. Lee AY, Raya AK, Kymes SM, Shiels A, Brantley MA Jr. Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab. Br J Ophthalmol. 2009 May. 93(5):610-3. [Medline].

34. Zhang J, Li S, Hu S, Yu J, Xiang Y. Association between genetic variation of complement C3 and the susceptibility to advanced age-related macular degeneration: a meta-analysis. BMC Ophthalmol. 2018 Oct 23. 18 (1):274. [Medline]. [Full Text].

35. Lin WY, Lee WC. Incorporating prior knowledge to facilitate discoveries in a genome-wide association study on age-related macular degeneration. BMC Res Notes. 2010 Jan 28. 3:26. [Medline].

36. Jakobsdottir J, Conley YP, Weeks DE, Mah TS, Ferrell RE, Gorin MB. Susceptibility genes for age-related maculopathy on chromosome 10q26. Am J Hum Genet. 2005 Sep. 77 (3):389-407. [Medline].

37. Dewan A, Liu M, Hartman S, Zhang SS, Liu DT, Zhao C, et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science. 2006 Nov 10. 314 (5801):989-92. [Medline].

38. Yang Z, Camp NJ, Sun H, Tong Z, Gibbs D, Cameron DJ, et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science. 2006 Nov 10. 314 (5801):992-3. [Medline].

Lucia Sobrin, MD, MPH Assistant Professor of Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear Infirmary

Disclosure: Nothing to disclose.

Johanna M Seddon, MD, SM Professor of Ophthalmology, Tufts University School of Medicine; Director, Ophthalmic Epidemiology and Genetics Service, New England Eye Center, Tufts Medical Center

Johanna M Seddon, MD, SM is a member of the following medical societies: American Academy of Ophthalmology, American College of Epidemiology, American Medical Association, American Society of Retina Specialists, Macula Society, Retina Society

Disclosure: Received tufts medical center has filed a patent application related to some of the work reported from Tufts Medical Center for other.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Karl S Roth, MD Retired Professor and Chair, Department of Pediatrics, Creighton University School of Medicine

Karl S Roth, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, American College of Nutrition, American Pediatric Society, American Society for Nutrition, American Society of Nephrology, Association of American Medical Colleges, Medical Society of Virginia, New York Academy of Sciences, Sigma Xi, Society for Pediatric Research, Southern Society for Pediatric Research

Disclosure: Nothing to disclose.

Supported by the Macular Degeneration Research Fund, Tufts Medical Center, Tufts University School of Medicine, Boston, MA; Massachusetts Lions Eye Research Fund, Inc., New Bedford, MA; Research to Prevent Blindness, Inc., New York, NY.